Evidence map›Paper›PMID 31300733›Full record

ArticleOncogene2019

Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression.

Zhenlong Chen, Rui Ren, Daiwei Wan, Yilin Wang, Xiaofeng Xue, Min Jiang, Jiaqing Shen, Ye Han, Fei Liu, Jianming Shi and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. iScience · 2026
    Article
  4. Article
  5. Construction and Analysis of circRNA-miRNA-mRNA Regulatory Networks.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Zhenlong ChenDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Rui RenDepartment of General Surgery, the Second Affiliated Hospital of Soochow University, 215000, Suzhou, China.
Daiwei WanDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Yilin WangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China. linglingwangyi@126.com.
Xiaofeng XueDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Min JiangDepartment of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Jiaqing ShenDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Ye HanDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Fei LiuDepartment of Gastroenterology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Jianming ShiDepartment of Oncology, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, 215002, Suzhou, China.
Yuting KuangDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China.
Wei LiDepartment of Oncology, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China. liwei10@suda.edu.cn.
Qiaoming ZhiDepartment of General Surgery, the First Affiliated Hospital of Soochow University, 215006, Suzhou, China. strexboy@163.com.
First Affiliated Hospital of Soochow University · CNSoochow University · CNFudan University Shanghai Cancer Center · CNNanjing Medical University · CNSecond Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CircRNAs have been reported to exert momentous roles in regulating pathophysiological process and guiding clinical diagnosis and treatment in colorectal cancer (CRC). However, there are still a lot of circRNAs that need to be unearthed. In this study, we evaluated the expression profile of circRNAs in 10 CRC tissues and their corresponding normal-appearing tissues (NATs) by microarray, and identified that hsa_circ_101555 (circ101555) was significantly up-regulated in tumor tissues and closely related to the prognosis of CRC patients. A specific close loop structure of circ101555 was described, which was generated by back-splicing of the host gene CSNK1G1 and showed greater stability than the linear RNA. The results in vitro and in vivo showed that silencing circ101555 expression significantly suppressed cell proliferation, induced apoptosis and impaired the DNA repair capacity of CRC cells, while rescue experiments suggested that down-expression of miR-597-5p could significantly attenuate the biological effects of circ101555 knockdown on CRC cells. Subsequent experiments in vitro, including double fluorescence in situ hybridization (D-FISH) analysis, RIP analysis and biotin-coupled probe pull down assay, confirmed that miR-597-5p was effectively enriched by circ101555, and circ101555 might serve as a sponge of miR-597-5p. Moreover, two putative oncogenes (CDK6 and RPA3) were identified as the miR-597-5p potential targets. Taken together, our results proved that circ101555 might function as a competing endogenous RNA of miR-597-5p to up-regulate CDK6 and RPA3 expression in CRC. Circ101555 could be a useful prognostic indicator in patients with CRC, and silence of circ101555 provided a new attractive therapeutic measure for CRC.

Indexed as

AnimalsBinding, CompetitiveCell Line, TumorColorectal NeoplasmsCyclin-Dependent Kinase 6Disease ProgressionDNA-Binding ProteinsFemaleGene Expression Regulation, NeoplasticHCT116 CellsHEK293 CellsHT29 CellsHumansMaleMiceMice, Inbred BALB CCDK6 protein, humanCyclin-Dependent Kinase 6DNA-Binding ProteinsMicroRNAsMIRN597 microRNA, humanRNA, CircularRPA3 protein, human

Identifiers

PMID31300733
OpenAlexW2961178997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.